RankingsPricing
  1. US-listed companies
  2. STAAR SURGICAL CO
  3. Financials
  4. Stock-based compensation

STAAR SURGICAL COSTAA

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Dec 27, 202427+15.71%
Dec 29, 202324+15.44%
Dec 30, 202220+39.48%
Dec 31, 202115+20.25%
Jan 1, 202112+15.16%
Jan 3, 202011+55.97%
Dec 28, 20187+113.92%
Dec 29, 20173-63.06%
Dec 30, 20169+159.02%
Jan 1, 20163-29.14%
Jan 2, 20155+3.88%
Jan 3, 20144+39.93%
Dec 28, 20123+67.61%
Dec 30, 20112

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)